Syndromic testing with mariPOC enables simultaneous diagnosis of COVID-19, RSV, influenza and more.
Antigen tests for professional use
The mariPOC rapid tests, which identify several pathogens at once, are best suited for decentralized diagnostics, such as point-of-care testing in health centres, private clinics, as well as hospital emergency departments.
Fast and comprehensive testing guarantees correct diagnosis without delay.
Automated test system
The mariPOC test system enables rapid and accurate diagnosis in acute infections. Multiple pathogens are tested from a single clinical sample simultaneously. The quality of the results is ensured by a sophisticated internal autoverification system.
The easy-to-use test system combines specific antigen detection with a unique diagnostic technology developed in Finland.
Preparing for the flu season
Not sure if it's COVID-19, influenza or a common cold? Find out with mariPOC Respi+ test! The Respi+ is a broad test panel covering 11 pathogens for syndromic testing of respiratory tract infections. Accurate and fast diagnosis enables optimal treatment and quick isolation measures.
Respi+ test is 10 times more likely to identify the correct pathogen than COVID testing alone.
News
mariPOC COVID-19 tests are suitable for travel certificates in the EU
The use of the mariPOC SARS-CoV-2, Respi+ and Quick Flu+ tests for EU COVID certificates...
Press release: ArcDia launches a quick and automated COVID-19 antigen test with superior performance
Turku, Finland, March 3rd, 2021 – the Finnish medical device manufacturer ArcDia International Ltd has...
Press release: Bruker to distribute ArcDia’s mariPOC® products for automated antigen POCT of COVID-19 and other infectious diseases in Central Europe
Turku, September 10th 2020 – ArcDia International Oy Ltd (“ArcDia”), developer and manufacturer of the...
Events
ECCMID 2022, Lisbon, Portugal
ArcDia’s mariPOC team will be present and available for meetings at ECCMID2022 in Lisbon April 23rd...
NSCMID 2021
Come meet us at NSCMID conference 2021 (3rd- 6th September, Turku)! Our team will be...
2nd International Conference Trends in Influenza Research
ArcDia’s R&D director Janne O. Koskinen speech at the online conference. mariPOC® technology designed for...
Get the latest news from ArcDia!
We send around 5 newsletters a year to keep you up-to-date on our latest news.